Skip to main content
Caplight Logo









Genix.ai

Genix.ai

Private
Bangalore UrbanHealthcare & Life Scienceshttps://genix.ai/

Last Round

Accelerator

Feb 1, 2023

Company Overview

Genix.ai is a healthcare technology company that develops AI-native platforms for clinical genomics, diagnostics, and precision medicine.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Medical AI, Biotechnology, Healthcare Analytics, ML Platforms

Business Model

B2B

Customer Profile

Subscription SaaS, Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

clinical genomicsprecision medicinegenomic sequencingbioinformaticsnext-generation sequencingNGSvariant interpretationbiomarker detectionmedical AIhealth techat-home DNA testinggenomic data analysismolecular dockingclinical decision supportgenomics as a service

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Genix.ai Comparables

Compare Genix.ai with similar companies based on industry and business-model similarity.

Genix.ai comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Vgenomics
83%
My Genome Screen
80%
4baseCare
77%

Genix.ai Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorFeb 1, 2023

Key People

Founding team and executive leadership

Gnanavel Mutharasu

Founder and CEO

Founding Team

Baskaran Dharmalingam

Chief Technology Officer

Executive Team

Genix.ai Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 7, 2026

    Grew 100% QoQ, from 3 to 6 employees.

  • Feb 6, 2026

    Grew 150% QoQ from 2 to 5 employees.

Recent news

Latest coverage and updates

  • receives_awardAug 4, 2026

    Genix received award Silver Award in the Healthcare Innovation category at Medicall Healthcare Innovation Awards 2026 on Aug 4th '26.

Genix.ai Filings

Explore SEC and related filing metadata, where available.

Genix.ai filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Genix.ai's valuation, stock price, and market status.

Is Genix.ai a public or private company?

Genix.ai is a private company.

What is the current stock price of Genix.ai?

Genix.ai is a private company with no public stock price. Caplight tracks Genix.ai's secondary market activity and provides MarketPrice estimates to Caplight users.

How much is Genix.ai worth (valuation)?

Valuation information for Genix.ai is not publicly available.

Can I buy Genix.ai stock?

Genix.ai shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Genix.ai's last funding round?

Genix.ai's most recent funding round was Accelerator on February 1, 2023.

Who are the main investors in Genix.ai?

Key investors in Genix.ai include Association for Bio-inspired Leaders & Entrepreneurs at SASTRA TBI.

Will Genix.ai IPO soon?

No public IPO plans have been announced for Genix.ai.

How can I track Genix.ai secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Genix.ai's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBangalore Urban
Employee Range6
Year Founded2021
Last FundingFeb 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?